-
Mashup Score: 23EV-302: Enfortumab Vedotin and Pembrolizumab - 1 month(s) ago
Thomas Powles, MBBS, MRCP, MD, joins the Oncology Brothers, Rohit Gosain, MD, and Rahul Gosain, MD, to discuss the EV-302 study and the role of enfortumab vedotin plus pembrolizumab in the bladder cancer treatment landscape.
Source: www.targetedonc.comCategories: General Medicine News, Partners & KOLsTweet
To wrap our #Genitourinary #Cancer series, we talk about the recent @US_FDA approval of #Enfortumab + #Pembro w/ @tompowles1 Full Int: - https://t.co/dw576gmlSQ - https://t.co/W9PCzEMWKn - Also on the “Oncology Brothers” podcast #gusm #OncTwitter #MedTwitter @TargetedOnc https://t.co/vEwqTP6vEH